However, clinical data shows that about 70% of patients report significant improvement or resolution of nausea by week 8 to 12 of consistent treatment
The Plovanich data (2015, replicated since)
Additionally, comparing "GLP-1 medications" to "Ozempic specifically" presents a comparison between a larger group and a single item within that group, which may explain why the comparison appears uneven
Although breast examination has been supported by many cancer organisations, it should not be used as a substitute for clinical breast examination and mammography (154, 155)
AmbrosoneCZirpoliGHutsonAMcCannWMcCannSBarlowWet alDietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221)
To date, no FDA safety communication has identified colorectal cancer as a safety signal for GLP-1 receptor agonists